Netherlands· NL-c81a3af9cde6
Copalia 10 mg/160 mg, filmomhulde tabletten
A valsartan and amlodipine product containing amlodipinebesilaat + valsartan, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Valsartan and amlodipine is registered in 14 of 19 countries.
Countries holding a registration under ATC C09DB01 (valsartan and amlodipine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Valsartan and amlodipine · ATC C09DB01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AMLODIPINEBESILAAT + VALSARTAN
- Manufacturer
- Novartis Europharm Limited
- Country
- Netherlands (NL)
- ATC code
- C09DB01
- ATC class
- Valsartan and amlodipine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/06/372
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for valsartan and amlodipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valsartan and amlodipine · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DB01
Valsartan and amlodipine, as other registers publish it.
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz
- SwitzerlandAmlodipin Valsartan Sandoz 10mg/160mg, FilmtablettenSandoz Pharmaceuticals AG
- SwitzerlandAmlodipin Valsartan Sandoz 10mg/320mg, FilmtablettenSandoz Pharmaceuticals AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7b14fb6-771e-48c5-b5ad-20fd4617a453 GET /v1/drugs/d7b14fb6-771e-48c5-b5ad-20fd4617a453?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/copalia-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Valsartan And Amlodipine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73395",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSPOVIDON (E 1202)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"MACROGOL 4000",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"AMLODIPINEBESILAAT",
"VALSARTAN"
],
"leaflet_url": null,
"authorised_at": "2007/01/16",
"procedure_number": "EMEA/H/C/000774",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/06/372",
"additional_monitoring": "N"
}See everything about valsartan and amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.